Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?

Inherited metabolic diseases (IMDs) are rare heterogenous genetic conditions. Advanced technology and novel therapeutic developments have led to the improved life expectancy of patients with IMDs. Long-term, they require close surveillance from specialist adult metabolic providers. Healthcare transi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Jessica I., Stepien, Karolina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572070/
https://www.ncbi.nlm.nih.gov/pubmed/36233672
http://dx.doi.org/10.3390/jcm11195805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572070/
https://www.ncbi.nlm.nih.gov/pubmed/36233672
http://dx.doi.org/10.3390/jcm11195805

Ejemplares similares